Dyne Reports Progress Building Next-Generation Exon Skipping Franchise In DMD

 
• By Jessica Merrill
  
efficacy
Dyne's DMD drug continues to show efficacy in Phase I/II • Source: Shutterstock

More from Clinical Trials

More from R&D